Mixed Protamine Zinc Recombinant Insulin Lispro Injection(25R)（Wanbang Biopharma）

精蛋白锌重组赖脯胰岛素(25R)（万邦医药）

Report date: 2025/11/06 10:43:23

Base Information

Drug NameMixed Protamine Zinc Recombinant Insulin Lispro Injection(25R)（Wanbang Biopharma）
Drug Alias Name精蛋白锌重组赖脯胰岛素混合注射液(25R)（万邦医药）
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonistsInsulin ligand
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesFosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A